Pharmacy to Dose: The Critical Care Podcast
Pharmacy to Dose: The Critical Care Podcast
Nick Peters
Pharmacy to Dose: The Critical Care Podcast provides information related to critical care and its pharmacotherapy in a fun and entertaining manner while creating a network of Pharmacists and critical care practitioners. New episodes are released every two weeks. Each episode we bring in a special guest to discuss a disease state or medication, with your host Nick Peters.
Trauma Alert Part 1 Acute Management
Trauma Alert Part I: Acute ManagementSpecial Guest: Brian Gilbert, PharmD, BCCCP, BCPS Show Notes: https://pharmacytodose.files.wordpress.com/2020/11/trauma-part-1-show-notes.pdf Reference List: https://pharmacytodose.files.wordpress.com/2020/11/trauma-part-1-references.pdf 05:12 – Pre-arrival preparation; 14:19 – Pharmacist role on trauma team; 15:40 – Primary survey; 23:37 – Massive transfusion protocol; 27:00 – Viscoelastography; 40:34 – PCC administration and dosage; 44:40 – Calcium; 51:00 – RSI/PAD considerations; 56:10 – Open fractures and antibiotics; 58:37 – Elevated ICP management; 62:37 – Take-home points PharmacyToDose.Com@PharmacyToDose on Twitter/InstagramPharmacyToDose@Gmail.com
Nov 27
1 hr 10 min
2020 ACCP Annual Meeting Recap
2020 ACCP Annual Meeting RecapSpecial Guest: Anthony Hawkins, PharmD, BCCCP Reference List: https://pharmacytodose.files.wordpress.com/2020/11/2020-accp-annual-meeting-references.pdf 06:30 – Virtual v. in-person meetings; 30:35 – BIG announcement!; 34:15 – Poster sessions; 47:00 – Scientific sessions PharmacyToDose.Com@PharmacyToDose on Twitter/InstagramPharmacyToDose@Gmail.com
Nov 6
1 hr 48 min
Pulmonary Hypertension
Pulmonary HypertensionSpecial Guest: Brian Murray, PharmD, BCCCP Reference List: https://pharmacytodose.files.wordpress.com/2020/09/ph-references.pdf 03:38 – Recent changes in PH management; 05:05 – PH classification; 10:22 – PH functional classification; 13:15 – PH diagnosis; 16:00 – Vasoreactivity challenge; 18:51 – Drug-induced PH; 21:08 – Short- and long-term PAH treatment goals; 23:50 – PH risk factors; 26:00 – Modifying outpatient PH medications/medication regimens; 33:03 – Fluid management in PH; 35:37 – VTE prophylaxis/treatment in PAH; 38:32 – Management of arrhythmias in PAH; 41:35 – CCB for PH treatment; 46:24 – Comparative studies in PH; 47:37 – Prostacyclins; 71:30 – Endothelin receptor antagonists; 76:04 – Phosphodiesterase inhibitors; 77:00 – sGC stimulator; 80:00 – Preferred treatment of PAH?; 84:53 – Vasopressors in patients with PH; 88:50 – Acute RV decompensation; 92:32 – Effect of positive pressure ventilation on PH; 94:55 – Management of outpatient PH infusion pumps; 97:22 – Take-home points PharmacyToDose.Com@PharmacyToDose on Twitter/InstagramPharmacyToDose@Gmail.com
Sep 14
1 hr 43 min
Antithrombotic & Anticoagulant Therapy with Cardiac Devices
Antithrombotic and Anticoagulant Therapy with Cardiac DevicesSpecial Guest: Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS (AQ-Cardiology), CACP Show Notes: https://pharmacytodose.files.wordpress.com/2020/08/ap-and-ac-with-cardiac-devices-show-notes.pdf Reference List: https://pharmacytodose.files.wordpress.com/2020/08/ap-and-ac-with-cardiac-devices-references.pdf 04:35 – MCS Overview; Case I; 07:45 – IABP Overview; Case I Continued; 17:17 – IABP Anticoagulation; Case I Continued; 24:03 – Impella Overview; Case IIl; 31:50 – Impella Anticoagulation; Case II Continued; 52:00 – LVAD thrombosis/bleeding management; Case III; 62:47 – Anticoagulation with Watchmen device; Case IV; 72:20 – TAVR overview; Case V; 80:45 – IV cangrelor; 82:37 – Does MCS reduce mortality?; 84:28 – Future research; 85:25 – Take-home points PharmacyToDose.Com@PharmacyToDose on Twitter/InstagramPharmacyToDose@Gmail.com
Aug 26
1 hr 32 min
Pediatric Critical Care Part I
Pediatric Critical Care Part ISpecial Guest: Joseph LaRochelle, PharmD, BCPPS, FCCP Resource List: https://pharmacytodose.files.wordpress.com/2020/08/pediatric-critical-care-part-i-resources.pdf 04:22 – Applying adult principles to kids?; 06:01 – Neonatal/pediatric vital signs; 10:25 – Pediatric/neonatal PK changes; 20:34 – Cytochrome P450 metabolism; 31:20 – Pediatric renal function/elimination; 44:22 – Pediatric v. adult dosing; 51:10 – Pediatric medication safety principles; 60:45 – Memorizing pediatric dosing; 70:13 – Pediatric weights; 74:26 – Pediatric Pharmacist training; 84:20 – Advice for Pharmacists; 86:43 – Take-home points PharmacyToDose.Com@PharmacyToDose on Twitter/InstagramPharmacyToDose@Gmail.com
Aug 13
1 hr 38 min
Ventricular Arrhythmias
Ventricular ArrhythmiasSpecial Guest: Matthew Wanat, PharmD, BCPS, BCCCP, FCCM Show Notes: https://pharmacytodose.files.wordpress.com/2020/07/ventricular-arrhythmias-show-notes.pdf Reference List: https://pharmacytodose.files.wordpress.com/2020/07/ventricular-arrhythmias-references.pdf 04:00 – What are arrhythmias?; 05:30 – Why are arrhythmias harmful/dangerous?; 06:58 – Risk factors; 09:12 – Common atrial arrhythmias; 10:19 – General arrhythmia treatment principles; 12:45 – When to use rhythm control for AF; 14:37 – Adenosine; 22:04 – Non-sustained VT/PVCs; 27:00 – Monomorphic v. Polymorphic VT; 30:53 – Torsades de Pointes; 34:16 – QTc prolongation; 42:18 – VF v. VT; 43:29 – Pulseless VT/VF; 49:30 – Amiodarone; 54:55 – Lidocaine/Mextiletine; 64:10 – Sotalol; 67:40 – Sodium channel blockers; 70:25 – Isoproterenol; 73:43 – BB/CCB; 78:29 – Long-term management; 80:34 – Stroke risk with ventricular arrhythmias; 82:20 – Prevention; 83:40 – EKG Interpretation; 86:48 – Step-wise approach; 88:13 – Take-home points; 90:00 – Small talk PharmacyToDose.Com@PharmacyToDose on Twitter/InstagramPharmacyToDose@Gmail.com
Jul 26
1 hr 39 min
White Coats for Black Lives
White Coats for Black Lives Special Guests:Earnest Alexander, PharmD, BCCCP, FCCM Sheriff Gbadamosi, PharmD Jason Jones, PharmD, BCPS, BCCCP Reference List: https://pharmacytodose.files.wordpress.com/2020/07/white-coats-for-black-lives-references.pdf 05:01 – How did we get here?; 27:16 – What emotions have you felt over recent events?; 45:40 – Why is this movement different?; 51:30 – Are these protests necessary/effective to enact change?; 59:20 – Inequality within the criminal justice system; 71:50 – Differences in treatment/outcomes for black patients; 83:43 – Systemic racism within US healthcare system; 87:09 – Is this a public health issue?; 91:55 – Importance of the diversity on the healthcare team; 95:35 – Increased pressure/stress being a black team member; 100:20 – Being an anti-racist; 104:40 – “All Lives Matter”; 109:55 – Powerful/Impactful media recommendations or further reading; 118:37 – Being a productive ally to the Black Lives Matter movement; 123:38 – Final thoughts PharmacyToDose.Com@PharmacyToDose on Twitter/InstagramPharmacyToDose@Gmail.com
Jul 3
2 hr 12 min
Medication Dosing in CRRT
CRRT Medication DosingSpecial Guest: Bruce Mueller, PharmD, FCCP, FASN, FNKF Show Notes: https://pharmacytodose.files.wordpress.com/2020/06/medication-dosing-in-crrt-show-notes.pdfReference List: https://pharmacytodose.files.wordpress.com/2020/06/medication-dosing-in-crrt-references.pdf 04:05 – Effect of AKI on patient outcomes; 08:40 – Different RRT modalities; 13:56 – How long has CRRT been used?; 17:35 – CRRT for all ICU patients?; 22:06 – When to avoid CRRT; 23:28 – CRRT definitions; 43:20 – Medication underdosing on CRRT; 51:27 – Older CRRT dosing studies v. newer studies; 54:29 – Drug properties that increase CRRT clearance; 58:36 – Does CRRT modality affect medication clearance?; 60:02 – Antibiotic retiming; 61:20 – Drug reference dosing recommendations; 64:20 – Dosing when patient is on CRRT and not in AKI; 66:40 – Anticoagulation for CRRT; 75:13 – Hybrid CRRT modalities; 81:45 – General dosing considerations; 83:23 – CRRT dosing drug references PharmacyToDose.Com@PharmacyToDose on Twitter/InstagramPharmacyToDose@Gmail.com
Jun 18
1 hr 32 min
Aneurysmal Subarachnoid Hemorrhage
Aneurysmal Subarachnoid HemorrhageSpecial Guest: Casey May, PharmD, BCCCP Show Notes: https://pharmacytodose.files.wordpress.com/2020/06/asah-show-notes.pdf Reference List: https://pharmacytodose.files.wordpress.com/2020/06/asah-references.pdf 02:51 – Types of intracerebral bleeds; 06:19 – Types of subarachnoid hemorrhage; 08:25 – Pathophysiology of aSAH; 10:45 – Risk factors; 12:48 – Classic aSAH presentation; 16:36 – Classificiation systems; 22:25 – Prioritizating acute management of aSAH; 25:15 – Blood pressure goals; 26:21 – Preferred anti-HTN agent?; 28:25 – Biggest concerns with anti-HTN agents; 31:08 – ICP management; 35:40 – Surgical clipping v. Endovascular coiling; 42:51 – Cerebral vasospasms and delayed cerebral ischemia; 55:07 – Nimodipine in aSAH; 68:20 – DVT prophylaxis; 73:48 – Seizure prophylaxis; 76:30 – Augmented renal clearance; 83:56 – Take-home points  PharmacyToDose.Com@PharmacyToDose on Twitter/InstagramPharmacyToDose@Gmail.com
Jun 3
1 hr 34 min
Acute Liver Failure
Acute Liver FailureSpecial Guest: Stephanie Bass, PharmD, BCPS, BCCCP Show Notes: https://pharmacytodose.files.wordpress.com/2020/05/acute-liver-failure-show-notes.pdf Reference List: https://pharmacytodose.files.wordpress.com/2020/05/acute-liver-failure-references.pdf 03:05 – Stephanie’s interest in the liver; 05:54 – Diagnosing ALF; 07:20 – Does having liver disease increase ALF risk?; 09:00 – Ultimate goal when treating ALF; 10:07 – Patient presentation; 11:58 – Common causes of ALF; 13:30 – ICP and cerebral edema management in ALF; 15:50 – PAD management in ALF; 18:55 – Acute hepatic encephalopathy management; 21:00 – Trending ammonia levels?; 22:25 – NAC for APAP overdose ALF; 27:11 – NAC for non-APAP overdose ALF; 30:23 – Albumin for ALF fluid resuscitation; 34:33 – Vasopressor use; 36:53 – Blood pressure goals; 40:00 – TEG for bleeding risk assessment; 43:45 – Hemostatic agents for coagulopathy; 46:18 – Anticoagulant of choice; 47:59 – Hepatic dose adjustments; 52:12 – Medication dosing with MARS/RRT; 54:00 – Medications to avoid; 56:02 – Transplant considerations; 58:24 – Take-home points PharmacyToDose.Com@PharmacyToDose on Twitter/InstagramPharmacyToDose@Gmail.com
May 19
1 hr 7 min
Load more